Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0815 | 0.961 | 0.9579 |
Mycobacterium tuberculosis | Probable bacterioferritin BfrA | 0.001 | 0 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0268 | 0.3081 | 0.253 |
Brugia malayi | RNA binding protein | 0.0748 | 0.8811 | 0.8716 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0815 | 0.961 | 0.9557 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0815 | 0.961 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0815 | 0.961 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0815 | 0.961 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0748 | 0.8811 | 0.9168 |
Schistosoma mansoni | tar DNA-binding protein | 0.0748 | 0.8811 | 0.9168 |
Echinococcus granulosus | GPCR family 2 | 0.0268 | 0.3081 | 0.3205 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0748 | 0.8811 | 0.8716 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0268 | 0.3081 | 0.3205 |
Schistosoma mansoni | hypothetical protein | 0.0268 | 0.3081 | 0.3205 |
Schistosoma mansoni | hypothetical protein | 0.0268 | 0.3081 | 0.3205 |
Loa Loa (eye worm) | hypothetical protein | 0.0848 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0111 | 0.1208 | 0.0509 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0815 | 0.961 | 0.5 |
Giardia lamblia | Kinase, PLK | 0.0815 | 0.961 | 0.5 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0815 | 0.961 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0815 | 0.961 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0404 | 0.4696 | 0.4886 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.001 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0848 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Mycobacterium tuberculosis | Bacterioferritin BfrB | 0.001 | 0 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0111 | 0.1208 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.058 | 0.6797 | 0.6357 |
Brugia malayi | N-terminal motif family protein | 0.018 | 0.2023 | 0.1389 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0748 | 0.8811 | 0.9168 |
Schistosoma mansoni | tar DNA-binding protein | 0.0748 | 0.8811 | 0.9168 |
Loa Loa (eye worm) | RNA binding protein | 0.0748 | 0.8811 | 0.8648 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0268 | 0.3081 | 0.213 |
Schistosoma mansoni | hypothetical protein | 0.058 | 0.6797 | 0.7073 |
Trypanosoma brucei | polo-like protein kinase | 0.0815 | 0.961 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0748 | 0.8811 | 0.8648 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0268 | 0.3081 | 0.213 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0268 | 0.3081 | 0.3205 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0111 | 0.1208 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0111 | 0.1208 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0268 | 0.3081 | 0.3205 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0748 | 0.8811 | 0.8648 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.005 | 0.0474 | 0.0494 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0111 | 0.1208 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0748 | 0.8811 | 0.9168 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.0474 | 0.0494 |
Echinococcus multilocularis | GPCR, family 2 | 0.0268 | 0.3081 | 0.3205 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.001 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0268 | 0.3081 | 0.3205 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0268 | 0.3081 | 0.3205 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0815 | 0.961 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0748 | 0.8811 | 0.9168 |
Echinococcus multilocularis | tar DNA binding protein | 0.0748 | 0.8811 | 0.9168 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0268 | 0.3081 | 0.253 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0404 | 0.4696 | 0.4886 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0815 | 0.961 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0268 | 0.3081 | 0.3205 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.058 | 0.6797 | 0.6543 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.2023 | 0.0927 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0848 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0815 | 0.961 | 1 |
Schistosoma mansoni | kinase | 0.0414 | 0.4824 | 0.502 |
Brugia malayi | TAR-binding protein | 0.0748 | 0.8811 | 0.8716 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.005 | 0.0474 | 0.0494 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.